Free Trial

Citizens Jmp's Rating of Nuvation Bio on 9/16/2026

On September 16, 2026, Citizens Jmp updated its outlook on Nuvation Bio (NYSE:NUVB) with the action "Reiterated Rating", keeping a "Market Outperform" rating. MarketBeat All Access subscribers can view the full ratings details, 12-month ROI, historical price target changes, and related news coverage on this page.

unlock icon  Upgrade to MarketBeat All Access

This premium research tool is available to MarketBeat All Access subscribers only. Log in to your account or sign up below.

Already have an account? Log in here.

More Ratings from Citizens Jmp

DateCompanyAction
10/14/2026
Exp World Holdings, Inc. stock logo
AGNT
Exp World
Initiated Coverage
10/14/2026
Compass, Inc. stock logo
COMP
Compass
Initiated Coverage
10/14/2026
Douglas Elliman Inc. stock logo
DOUG
Douglas Elliman
Initiated Coverage
10/14/2026
Real REMAX Group Inc stock logo
REAX
Real REMAX Group
Initiated Coverage
10/14/2026
Biomea Fusion, Inc. stock logo
BMEA
Biomea Fusion
Reiterated Rating
10/14/2026
Safehold Inc. stock logo
SAFE
Safehold
Reiterated Rating
More Ratings From Citizens Jmp